Why are human cells resistant to malignant cell transformation in vitro?

Area of Science:

• Cell biology
• Cancer research
• Molecular oncology

Background:

• Human cell transformation is rare compared to rodent cells, even with carcinogens.
• Malignant transformation in vitro is a complex process, often requiring multiple steps.

Purpose of the Study:

• To investigate the resistance of human cells to malignant transformation in vitro.
• To elucidate the distinct phases involved in human cell transformation.

Main Methods:

• Reviewing existing literature on human cell transformation protocols.
• Analyzing the two-phase model: immortalization (Phase I) and malignant transformation (Phase II).
• Examining the use of viral agents (SV40, HPV) and oncogenes for Phase I, followed by chemical carcinogens for Phase II.

Main Results:

• Human cells typically require a two-phase transformation process (immortalization followed by malignant transformation).
• Rodent cells can be transformed more easily by a single carcinogenic agent.
• Immortalization appears to be a prerequisite for subsequent malignant transformation in human cells.

Conclusions:

• Human cells exhibit resistance to single-agent-induced malignant transformation.
• A sequential two-phase approach, involving immortalization then malignant transformation, is often necessary for human cell transformation.
• Understanding these phases is crucial for cancer research and developing therapeutic strategies.